Evidence map›Paper›PMID 37738335›Full record

ArticleScience advances2023

Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women.

Kristine Blix, Ida Laake, Lene Juvet, Anna Hayman Robertson, Ida Henriette Caspersen, Siri Mjaaland, Siri N Skodvin, Per Magnus, Berit Feiring, Lill Trogstad

Abstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Abnormal uterine bleeding diagnoses and care following COVID-19 vaccination.American journal of obstetrics and gynecology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kristine BlixDepartment of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0009-0007-7838-0161
Ida LaakeDepartment of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-0546-896X
Lene JuvetDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-3317-8203
Anna Hayman RobertsonDepartment of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0001-6295-0528
Ida Henriette CaspersenCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-2591-8435
Siri MjaalandDepartment of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-3870-5861
Siri N SkodvinCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-4545-2513
Per MagnusCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-6427-4735
Berit FeiringDepartment of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-1505-1671
Lill TrogstadDepartment of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-9557-5725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between coronavirus disease 2019 (COVID-19) vaccination and vaginal bleeding among nonmenstruating women is not well studied. The Norwegian Institute of Public Health followed several cohorts throughout the pandemic and early performed a systematic data collection of self-reported unexpected vaginal bleeding in nonmenstruating women. Among 7725 postmenopausal women, 7148 perimenopausal women, and 7052 premenopausal women, 3.3, 14.1, and 13.1% experienced unexpected vaginal bleeding during a period of 8 to 9 months, respectively. In postmenopausal women, the risk of unexpected vaginal bleeding (i.e., postmenopausal bleeding) in the 4 weeks after COVID-19 vaccination was increased two- to threefold, compared to a prevaccination period. The corresponding risk of unexpected vaginal bleeding after vaccination was increased three- to fivefold in both nonmenstruating peri- and premenopausal women. In the premenopausal women, Spikevax was associated with at 32% increased risk as compared to Comirnaty. Our results must be confirmed in future studies.

Indexed as

COVID-19COVID-19 VaccinesFemaleHumansPandemicsSelf ReportUterine HemorrhageCOVID-19 Vaccines

Identifiers

PMID37738335
PMCPMC10516485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.